2,4-Dichloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine

Catalog No.: 
ACXYBU543
CAS No.: 
2139336-89-1
Molecular Formula: 
C6H5Cl2N3
Molecular Weight: 
190.03
2,4-Dichloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$177.00In stockInquiry
100mg98%$229.00In stockIn stock
250mg98%$381.00In stockIn stock
1g98%$838.00In stockIn stock

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,4-Dichloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine
IUPAC Name2,4-dichloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine
MDL No.MFCD32063338
Molecular FormulaC6H5Cl2N3
Molecular Weight190.03
SMILESClC1=C2C(NCC2)=NC(Cl)=N1
InChI KeyNJYXRIIEMJOTRJ-UHFFFAOYSA-N
Synonym5H-Pyrrolo[2,3-d]pyrimidine, 2,4-dichloro-6,7-dihydro-;2,4-Dichloro-6,7-dihydro-5H-pyrrolo[2,3-d]pyrimidine
CAS No.2139336-89-1

Safety Data

Pictogram
PICTOGRAM
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACXYBU543 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAPFG301 route compound structure diagram
    ACAPFG3011520452-96-3In Stock
  2. Then
  3. ACXYBU543 route product structure diagram
    ACXYBU5432139336-89-1In Stock
Inquiry

2. ACXYBU543 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKYQT046 route compound structure diagram
    ACKYQT04690213-66-4In Stock
  2. Then
  3. ACXYBU543 route product structure diagram
    ACXYBU5432139336-89-1In Stock
Inquiry

3. ACXYBU543 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXYBU543 route product structure diagram
    ACXYBU5432139336-89-1In Stock
Inquiry

Comments (0)